Aarti Drugs Valuation
| AARTIDRUGS | 333.65 10.80 3.14% |
At this time, the firm appears to be overvalued. Aarti Drugs Limited shows a prevailing Real Value of USD251.45 per share. The current price of the firm is USD333.65. Our model approximates the value of Aarti Drugs Limited from analyzing the firm fundamentals such as Current Valuation of 38.1 B, profit margin of 0.07 %, and Return On Equity of 0.12 as well as examining its technical indicators and probability of bankruptcy.
Price Book 2.5454 | Enterprise Value 38.1 B | Enterprise Value Ebitda 12.9111 | Price Sales 1.3491 | Trailing PE 20.7001 |
Overvalued
Today
Please note that Aarti Drugs' price fluctuation is very steady at this time. Calculation of the real value of Aarti Drugs Limited is based on 3 months time horizon. Increasing Aarti Drugs' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Aarti stock is determined by what a typical buyer is willing to pay for full or partial control of Aarti Drugs Limited. Since Aarti Drugs is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Aarti Stock. However, Aarti Drugs' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 333.65 | Real 251.45 | Hype 355.97 | Naive 364.62 |
The intrinsic value of Aarti Drugs' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Aarti Drugs' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Aarti Drugs Limited helps investors to forecast how Aarti stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Aarti Drugs more accurately as focusing exclusively on Aarti Drugs' fundamentals will not take into account other important factors: Aarti Drugs Cash |
|
Aarti Drugs Total Value Analysis
Aarti Drugs Limited is presently anticipated to have takeover price of 38.1 B with market capitalization of 31.44 B, debt of 5.64 B, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Aarti Drugs fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
38.1 B | 31.44 B | 5.64 B |
Aarti Drugs Investor Information
About 61.0% of the company shares are held by company insiders. The book value of Aarti Drugs was presently reported as 139.96. The company recorded earning per share (EPS) of 16.64. Aarti Drugs Limited last dividend was issued on the 4th of February 2025. The entity had 4:1 split on the 30th of September 2020. Based on the key indicators related to Aarti Drugs' liquidity, profitability, solvency, and operating efficiency, Aarti Drugs Limited is performing exceptionally good at this time. It has a great probability to report excellent financial results in April.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Total Cash From Operating Activities | 4.3 B | 4.1 B |
|
| |||||
| Operating Income | 3.4 B | 3.2 B |
|
|
Aarti Drugs Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Aarti Drugs has an asset utilization ratio of 103.15 percent. This connotes that the Company is making USD1.03 for each dollar of assets. An increasing asset utilization means that Aarti Drugs Limited is more efficient with each dollar of assets it utilizes for everyday operations.Aarti Drugs Ownership Allocation
Aarti Drugs holds a total of 91.27 Million outstanding shares. Aarti Drugs Limited shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 60.52 percent of Aarti Drugs Limited outstanding shares that are owned by insiders signifies that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Aarti Drugs Profitability Analysis
The company reported the revenue of 25.09 B. Net Income was 1.71 B with profit before overhead, payroll, taxes, and interest of 8.09 B.About Aarti Drugs Valuation
The stock valuation mechanism determines Aarti Drugs' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Aarti Drugs Limited based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Aarti Drugs. We calculate exposure to Aarti Drugs's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Aarti Drugs's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 4 B | 3.1 B |
Aarti Drugs Quarterly Retained Earnings |
|
Additional Tools for Aarti Stock Analysis
When running Aarti Drugs' price analysis, check to measure Aarti Drugs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aarti Drugs is operating at the current time. Most of Aarti Drugs' value examination focuses on studying past and present price action to predict the probability of Aarti Drugs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aarti Drugs' price. Additionally, you may evaluate how the addition of Aarti Drugs to your portfolios can decrease your overall portfolio volatility.